Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- Diagnostic concordance with gold standard diagnostic procedures
研究概览
简要总结
Encephalopathies are a group of central nervous system (CNS) affection with heterogeneous etiology. Several causes have been recognized including neurodegenerative, vascular, infectious, autoimmune, toxic or allergic affections or secondary to systemic disorders. While 30-50% of acute encephalitis remains without etiological definition, definitive criteria for neurodegenerative diseases are usually unavailable in vivo and possible or probable definitions are used. The Olfactory mucosa (OM) is the part of the nasal mucosa that carries the specialized sensory organ for the modality of smell; the olfactory epithelium is composed of five principal cell types including olfactory receptor neurons. A sample of OM may be collected through a rhinoscopy-guided brushing: it is well-accepted by patients, not-contraindicated in patients with raised intracranial pressure and associated with almost no side-effects. Nasal brushing has recently been proposed for the in vivo diagnosis of Creutzfeldt-Jakob disease (CJD).
Aims of the project are:
- Training of ear throat and nose (ETN), Infectious disease (ID) and neurology (NEU) specialists in the technique of nasal brushing;
- Conducting a prospective study comparing the use of nasal brushing with gold-standard criteria in the diagnosis of Encephalopathies;
- Increasing the diagnostic and prognostic power in the diagnosis of encephalopathies.
A prospective, case control, multicentric study enrolling 400 patients and 100 controls (patients with nasal stenosis undergoing rhinoscopy for clinical reasons). Patients will be diagnosed and followed according to international guidelines and local clinical practice. Cerebrospinal fluid and magnetic resonance imaging will be used, where indicated, for the diagnosis according to the clinical or radiological suspect.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •age>18 years;
- •signing a written informed consent (by the patients or his/her legal representant);
- •clinical suspect of encephalopathy (acute or subacute) including acute encephalitis, neurodegenerative disorders and HIV-associated neurocognitive disorders.
- •Inclusion criteria for controls:
- •age>18 years;
- •signing a written informed consent (by the patients or his/her legal representant); • clinical indication for rhinoscopy for stenotic disease of nasal sept or turbinates.
排除标准
- •Nasal anatomical abnormalities precluding the execution of nasal brushing;
- •Serious general conditions and/or comorbidities in patients for whom nasal brushing may be a risk factor precipitating their pre-existing condition;
- •Anti-coagulant treatment.
结局指标
主要结局
Diagnostic concordance with gold standard diagnostic procedures
时间窗: Single-visit
Positive and negative predictive values and correct classification rates of OM tests versus gold standard diagnostic procedures
次要结局
- Side effects of the nasal brushing(Up to 6 months after the procedure)
- Cytological and immunohistochemistry examination of nasal brushing smear (neuronal abnormalities and expression of specific markers according to the different aetiologies)(single-visit)
- OM markers of neuronal damage and amyloid deposition(single-visit)
研究者
Giovanni Di Perri
Professor of Infectious Diseases
University of Turin, Italy
